Lindbrook Capital »

Marinus Pharmaceuticals shares owned by Lindbrook Capital

Quarter-by-quarter ownership of Marinus Pharmaceuticals (MRNS) shares owned by Lindbrook Capital from 13F filings

Historical chart of Lindbrook Capital investment in Marinus Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Marinus Pharmaceuticals held by Lindbrook Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Marinus Pharmaceuticals by Lindbrook Capital

Quarter filed Position value Share count Share price at filing
2024-03-31 $2.2k 242 9.04
2023-12-31 $2.6k 242 10.87
2023-09-30 $1.9k 242 8.05

More positions owned by Lindbrook Capital

Vanguard Total Stk Mkt Etf (VTI)
Vanguard Total Intl Stock Idex Etf Etf (VXUS)
Golub Cap Bdc Cef (GBDC)
Apple Stock (AAPL)
Spdr S&p 500 Etf Trust Etf (SPY)
Ishares Russell 1000 Growth Etf Etf (IWF)
Nvidia Corporation Stock (NVDA)
Microsoft Stock (MSFT)
Rpar Risk Parity Etf Etf (RPAR)
Ishares Russell 1000 Value Etf Etf (IWD)
Amazon.com Stock (AMZN)
Powershares Qqq Tr Etf (QQQ)
Oaktree Specialty Lending Corp Cef (OCSL)
Vertex Pharmaceuticals In Stock (VRTX)
Broadcom Stock (AVGO)

View all positions for Lindbrook Capital

Top funds holding Marinus Pharmaceuticals

Eventide Asset Management
Franklin Resources
Cormorant Asset Management
venBio Select Advisor
Jennison Associates
Vanguard Group
Lion Point Capital
Bleichroeder
GMT Capital Corp
Ikarian Capital
Citadel Advisors
Opaleye Management
Standard Life Aberdeen
Point72 Asset Management
Superstring Capital Management

View all funds holding Marinus Pharmaceuticals